Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alpha 1-proteinase Inhibitor Deficiency”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchActive Not RecruitingNCT07193615
What this trial is testing

Study of YOLT-202 in the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha-1 Antitrypsin Deficiency (AATD)
RenJi Hospital 18
Testing effectiveness (Phase 2)WithdrawnNCT01183455
What this trial is testing

A Research Trial of Aralast NP in New Onset Diabetes (RETAIN) - Part II

Who this might be right for
Diabetes Mellitus, Type 1
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Not applicableEnded earlyNCT03823443
What this trial is testing

COPD Exacerbation Blood and Urine Biomarkers Study

Who this might be right for
Chronic Obstructive Pulmonary DiseaseAcute Exacerbation CopdAlpha-1 Anti-trypsin Deficiency
Columbia University 7
Early research (Phase 1)Study completedNCT05579431
What this trial is testing

A Phase 1, First-in-human Study of VX-634

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Vertex Pharmaceuticals Incorporated 127
Not applicableLooking for participantsNCT04157049
What this trial is testing

Alpha-1 Research Registry

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Alpha-1 Foundation 5,000
Not applicableStudy completedNCT02810327
What this trial is testing

Alpha-1 Carrier Genomics Study

Who this might be right for
Alpha-1 Antitrypsin DeficiencyEmphysemaCOPD+1 more
Medical University of South Carolina 117
Early research (Phase 1)Looking for participantsNCT06996756
What this trial is testing

Gene Therapy for Alpha 1- Antitrypsin Deficiency

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Weill Medical College of Cornell University 16
Testing effectiveness (Phase 2)Study completedNCT01054339
What this trial is testing

Safety & Efficacy Study of rAAV1-CB-hAAT for Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Beacon Therapeutics 9
Testing effectiveness (Phase 2)Study completedNCT00067756
What this trial is testing

4-PBA: Will it Increase the Level of Alpha 1-Antitrypsin(AAT) in Persons With AAT Deficiency?

Who this might be right for
Alpha 1-Antitrypsin Deficiency
University of Florida 12
Large-scale testing (Phase 3)Ended earlyNCT04204252
What this trial is testing

Phase III, Efficacy and Safety of "Kamada-AAT for Inhalation"

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Kamada, Ltd. 98
Post-approval studies (Phase 4)Looking for participantsNCT07135427
What this trial is testing

Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

Who this might be right for
Alpha 1-AntitrypsinCOPDAntibody Deficiency
University of Alabama at Birmingham 30
Early research (Phase 1)Ended earlyNCT02363946
What this trial is testing

ARC-AAT in Healthy Volunteer Subjects and Patients With Alpha-1 Antitrypsin Deficiency (AATD)

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Arrowhead Pharmaceuticals 65
Not applicableLooking for participantsNCT00500123
What this trial is testing

The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

Who this might be right for
Alpha-1 Antitrypsin Deficiency
University of Florida 50,000
Testing effectiveness (Phase 2)Study completedNCT02001688
What this trial is testing

Phase II, Safety and Efficacy Study of Kamada-alpha-1-antitrypsin (AAT) for Inhalation"

Who this might be right for
Alpha-1 Antitrypsin Deficiency
Kamada, Ltd. 36
Post-approval studies (Phase 4)WithdrawnNCT05466747
What this trial is testing

RYMPHYSIA for Alpha1-Proteinase Inhibitor (A1PI) Therapy in Adults With A1PI Deficiency and Chronic Obstructive Pulmonary Disease (COPD)-Emphysema

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)Alpha1-Antitrypsin Deficiency
Takeda
Not applicableStudy completedNCT01831739
What this trial is testing

Genomic Research in Sarcoidosis

Who this might be right for
Sarcoidosis
University of Pittsburgh 368
Not applicableEnrolling By InvitationNCT06892236
What this trial is testing

Preparation of IPSC for Cell Gene Editing for the Treatment of AATD

Who this might be right for
Alpha1-antitrypsin Deficiency
Fondazione IRCCS Policlinico San Matteo di Pavia 3
Not applicableWithdrawnNCT02273349
What this trial is testing

Lung Volume Reduction Coils for Emphysema in Alpha-1 Antitrypsin Deficiency

Who this might be right for
Alpha-1-Antitrypsin DeficiencyChronic Obstructive Lung DiseaseEmphysema
University Hospital, Saarland
Testing effectiveness (Phase 2)Ended earlyNCT04764448
What this trial is testing

Belcesiran in Patients With AATLD

Who this might be right for
Alpha 1-Antitrypsin Deficiency
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 16
Next Page